{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8748088",
  "DateCompleted": {
    "Year": "1996",
    "Month": "10",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "08",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0306-9877",
      "JournalIssue": {
        "Volume": "45",
        "Issue": "5",
        "PubDate": {
          "Year": "1995",
          "Month": "Nov"
        }
      },
      "Title": "Medical hypotheses",
      "ISOAbbreviation": "Med Hypotheses"
    },
    "ArticleTitle": "An enzymatic effect for cancer prevention and eradication.",
    "Pagination": {
      "StartPage": "465",
      "EndPage": "467",
      "MedlinePgn": "465-7"
    },
    "Abstract": {
      "AbstractText": [
        "As previously described in a series of hypotheses, cancer development depends on an unconvertable duplication mitosis caused by some abnormal supplement of the mitotic maturation promoting system which is paralyzed in the cancerous cell's cytoplasm. This abnormal supplement, which may be responsible for the cancer's development, must be a biochemical compound that could be eliminated by exposure to the action of certain enzymes. Accordingly, in order to prevent and eradicate cancer development in general, an enzyme which would destroy and eliminate the biochemical supplement needs to be identified, and a specific method of delivering the enzyme to the supplement needs to be devised."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Hirata Hospital, Kochi City, Japan."
          }
        ],
        "LastName": "Hirata",
        "ForeName": "Y",
        "Initials": "Y"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Med Hypotheses",
    "NlmUniqueID": "7505668",
    "ISSNLinking": "0306-9877"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Enzymes"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Actin Cytoskeleton"
    },
    {
      "QualifierName": [
        "enzymology"
      ],
      "DescriptorName": "Duodenum"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Enzyme Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Models, Biological"
    },
    {
      "QualifierName": [
        "etiology",
        "prevention & control"
      ],
      "DescriptorName": "Neoplasms"
    }
  ]
}